Literature DB >> 9228139

Reliability, validity, and sensitivity of a Swedish version of the revised and expanded Arthritis Impact Measurement Scales (AIMS2).

B Archenholtz1, A Bjelle.   

Abstract

OBJECTIVE: To evaluate the reliability, validity, and sensitivity of a Swedish version of the Arthritis Impact Measurement Scales (AIMS2) in patients with rheumatoid arthritis (RA).
METHODS: Reliability was assessed by a test-retest procedure with a 3-week interval and Cronbach's coefficient of internal consistency. Convergent validity was evaluated by correlation coefficients with the Health Assessment Questionnaire (HAQ), Mood Adjective Checklist (MACL), and disease activity variables. The sensitivity to change was assessed in 40 patients treated with disease modifying antirheumatic drugs, 24 mo after the start of the study.
RESULTS: Significant differences were found for the Walking and Bending, Arthritis Pain, and Work scales (p < 0.05) in the test-retest reliability study. Internal consistency coefficients for the AIMS2 scales were 0.68-0.91. Convergent validity was established by significant correlations between the different scales in AIMS2 and the HAQ, MACL, and disease activity variables. Sensitivity to change was observed in 5 of 11 scales in AIMS2.
CONCLUSION: After modifying some reliability problems due to a more differentiated scale and cultural differences between the Swedish and American patients with RA, the reliability, validity, and sensitivity to change of AIMS2 were found satisfactory.

Entities:  

Mesh:

Year:  1997        PMID: 9228139

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.

Authors:  Jiyeon Lee; Soo Hyun Kim; Seung Hei Moon; Eun-Hyun Lee
Journal:  Qual Life Res       Date:  2014-05-21       Impact factor: 4.147

2.  Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes.

Authors:  T Sanderson; M Morris; M Calnan; P Richards; S Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

3.  Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis.

Authors:  T Heiberg; A Finset; T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

4.  Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.

Authors:  Peter M ten Klooster; Martine M Veehof; Erik Taal; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

Review 5.  Patient-reported outcomes and their role in the assessment of rheumatoid arthritis.

Authors:  Deborah P Lubeck
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain.

Authors:  E Taal; J J Rasker; R P Riemsma
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

7.  The role of demographic and clinical variables in assessing the quality of life of outpatients with rheumatoid arthritis.

Authors:  Grażyna Bączyk; Katarzyna Kozłowska
Journal:  Arch Med Sci       Date:  2018-07-20       Impact factor: 3.318

8.  Swedish version of the multi dimensional health assessment questionnaire -- translation and psychometric evaluation.

Authors:  Kristina Areskoug Josefsson; Charlotte Ekdahl; Ulf Jakobsson; Gunvor Gard
Journal:  BMC Musculoskelet Disord       Date:  2013-06-04       Impact factor: 2.362

9.  Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremity.

Authors:  Ann B I Bremander; Ingemar F Petersson; Ewa M Roos
Journal:  Health Qual Life Outcomes       Date:  2003-10-17       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.